Pharmacy Resident Seminar: Chronic Lymphocytic Leukemia (CLL) Treatment Updates: iGen and Beyond

Please join us for our next Pharmacy Resident Seminar Presentation of Tuesday, October 16, 2018, in Chicago campus, Room 134-1 and Rockford, Room E226

Chronic Lymphocytic Leukemia (CLL) Treatment Updates: iGen and Beyond--Benito Valdepeñas III, PharmD (PGY-1 Pharmacy Practice Resident)

A Knowledge-Based Activity

Agenda

Tuesday, October 16, 2018

12:30 pm - 1:20 pm

• Live Presentation: UIC College of Pharmacy Chicago - Room 134-1
• Live Broadcast: UIC College of Pharmacy Rockford - Room E226

Target Audience: Pharmacists

 Learning Objectives:

At the completion of this activity, the participant will be able to:

• Identify potential drug targets in the B Cell Receptor (BCR) signaling pathway for the treatment of chronic lymphocytic leukemia (CLL)
• Describe safety and efficacy data on the use of small molecule inhibitors in the treatment of chronic lymphocytic leukemia (CLL)
• Select an oncology treatment plan given a patient’s molecular profile and minimal residual disease (MRD) status

Fees: There is no charge for attending this activity.

Disclosure: Dr. Valdepeñas has no actual or potential conflicts of interest. Dr. Danziger is on the Speaker’s Bureau/Advisory Board for Allergan, The Medicines Company, and Merck. Dr. Anguiano is consultant for United Therapeutics HEOR and on the Speaker’s Bureau/ Advisory Board for United Therapeutics. Dr. Martin is a recipient of a grant/research support from Gilead and on the Speaker’s Bureau or Advisory Board for Gilead. Professor Moody is on the Speaker’s Bureau/Advisory Board for Shire Pharmaceuticals. All other speakers, members of the CE advisory committee and planning committee who contributed to this activity have no actual or potential conflicts of interest to disclose.

Statement of Continuing Pharmacy Education Credit:

The University of Illinois at Chicago College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.  This activity has been assigned ACPE Universal Activity Number 0016-0000-18-031-L01-P, for 1.0 contact hours (0.1 CEUs).  Attendance at the entire knowledge based activity, completion of the evaluation, and submission of NABP eProfile ID and MMDD are prerequisites for receiving continuing pharmacy education credit(s).  All ACPE credit awarded to participants must be uploaded to CPE Monitor ™ within 30 days of the activity date, so pharmacists are required to provide their e-Profile ID and date of birth (MMDD) at the time of the activity.  Please contact aquarl2@uic.edu if you do not see activity information listed within 30 days.  For more information and to set up your e-Profile visit: www.MyCPEmonitor.net.